Public Availability of Results of Trials Assessing Cancer Drugs in the United States

American Society of Clinical Oncology: July 22, 2013

Purpose To evaluate to what extent results of completed trials of cancer drugs conducted in the United States are publicly available at, as required by the Food and Drug Administration Amendments Act (FDAAA), or are published in journals.

Methods We searched for cancer trials governed by the FDAAA: phase II to IV trials assessing drugs in the United States with a primary completion date between December 26, 2007, and May 31, 2010. For each trial, we also searched PubMed to identify the publication of results. We assessed the cumulative percentages of posted or published results over time by using the Kaplan-Meier method. Read more